George Clinical and the China Anti-Cancer Association Australia launch inaugural research seminar.

26 SEPTEMBER, 2018 – (SYDNEY) In recognition of the largest non-English speaking ethnic groups in Australia, George Clinical, a leading Asia Pacific CRO, and the China Anti-Cancer Association Australia (CACA) have joined together to launch the inaugural CACA research seminar entitled: Cancer incidence, palliative care among Chinese migrants to Australia.

The event, which will be held at George Clinical's Sydney HQ, will consist of three important keynote talks by key health researchers and members of the Australia-Chinese community. The three talks include:

·       Cancer Incidence among Chinese Migrants to Australia 2007-2011: results from a national cohort study; Dr Xue Qin Yu, Senior Research Fellow, Cancer Research Division, Cancer Council NSW

·       Light in the Darkness - Information and Resources for Palliative Care Cancer Patients and Their Families with Chinese Background;  Dr George Zhang,   Research Project Officer, CanRevive Inc

·       Highlights from Chinese Conference on Oncology 2018;  Yaping Liu, Secretary-General, China Anti-Cancer Association Australia

"George Clinical has an extensive track record in the delivery of clinical trial services to the highest quality in both Australia and China," Dr Jacqueline Thorn, George Clinical's Commercial Director said in advance of tomorrow's seminar. "We have always taken a patient-centred approach to the delivery of our trials globally; and this seminar is a further example of our emphasis on science, service delivery and pragmatic trial solutions."

About George Clinical

George Clinical is a leading independent Asia-Pacific based clinical research organisation (CRO) with global capabilities differentiated by scientific leadership, innovation and extensive investigator networks. With staff operating in 15 countries, and with significant operations in the USA, China, India and the broader Asia Pacific region, George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and diagnostic customers, for all trial phases, registration and post-marketing trials.

About China Anti-Cancer Association Australia

The China Anti-Cancer Association was established in 1984 with the vision to be the leading non-governmental organization devoted to increase the survival rate, decrease the incidence and mortality rate of cancer, and improve the cancer control in China and the world. With over 140,000 professional members from hundreds of hospitals in China, it is one of the largest organisations of its type in the world.  CACA Australia was formed in April 2018 to build a special platform and channel between Australia and China to contribute to the prevention and treatment of cancer via organizing, mobilizing and supporting clinical, scientific and technological professionals in the field of oncology.

For more information, contact:

Michael Sydes

Marketing Communications Manager

msydes@georgeclinical.com